Edition:
India

People: Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

12.71USD
5 Aug 2020
Change (% chg)

-- (--)
Prev Close
$12.71
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
432,214
52-wk High
$19.36
52-wk Low
$4.52

Koppikar, Utpal 

Mr. Utpal Koppikar serves as Chief Financial Officer of the company since June 2018. Prior to joining Atara, from June 2011 to June 2018, Mr. Koppikar held several senior financial leadership positions at Gilead Sciences, including as Vice President of Corporate and Operations Finance, responsible for R&D, corporate, G&A, process development and manufacturing, and strategic sourcing. Prior to Gilead, from January 2001 to June 2011, he served in multiple finance roles of increasing responsibility at Amgen. Mr. Koppikar earned his B.S. in aerospace engineering at the University of Maryland and received a M.S. in aeronautical and astronautical engineering from Stanford University. He also holds an MBA in finance and marketing from The Anderson School at UCLA.

Basic Compensation

Total Annual Compensation, USD 595,481
Restricted Stock Award, USD 1,034,710
Long-Term Incentive Plans, USD --
All Other, USD 909,975
Fiscal Year Total, USD 2,540,170

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --